- Home
- NVCT vs RWT Comparison
NVCT vs RWT Comparison
Compare NVCT & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCT | RWT |
|---|---|---|
| Founded | 2020 | 1994 |
| Country | United States | United States |
| Employees | 13 | 351 |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 608.8M | 652.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVCT | RWT |
|---|---|---|
| Price | $19.31 | $4.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $10.00 | $6.82 |
| AVG Volume (30 Days) | 525.3K | ★ 3.5M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 12.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $26.59 |
| Revenue Next Year | N/A | $22.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.55 | $4.19 |
| 52 Week High | $29.28 | $6.97 |
Technical Indicators
Market Signals| Indicator | NVCT | RWT |
|---|---|---|
| Relative Strength Index (RSI) | 54.96 | 48.72 |
| Support Level | $18.02 | $4.19 |
| Resistance Level | $29.28 | $5.36 |
| Average True Range (ATR) | 1.18 | 0.18 |
| MACD | -0.31 | 0.02 |
| Stochastic Oscillator | 63.07 | 60.84 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About RWT Redwood Trust Inc.
Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.